The Discounted Cash Flow (DCF) valuation of Henan Lingrui Pharmaceutical Co Ltd (600285.SS) is 31.35 CNY. With the latest stock price at 21.76 CNY, the upside of Henan Lingrui Pharmaceutical Co Ltd based on DCF is 44.1%.
Based on the latest price of 21.76 CNY and our DCF valuation, Henan Lingrui Pharmaceutical Co Ltd (600285.SS) is a buy. buying 600285.SS stocks now will result in a potential gain of 44.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.4% | 8.1% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 22.12 - 56.01 | 31.35 |
| Upside | 1.6% - 157.4% | 44.1% |